immatics appoints Peter Chambré as chairman
November 12, 2012Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics
Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …
NHS: pharma needs to help more
November 12, 2012Sales and Marketing CCGs, NHS, pharma
A variety of senior figures in public health set out how they want the pharma industry to do more to …
Copper could replace precious metals in pharma production
November 9, 2012Manufacturing and Production Sweden, copper, manufacturing
Non-precious metals such as copper could be used as catalysts in pharmaceuticals production, replacing precious metals that are expensive and …
GSK guilty of off-label promotion
November 9, 2012Medical Communications, Sales and Marketing GSK, PMCPA, Revolade
GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …
Pharma treated as though ‘selling cyanide’
November 9, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead
APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …
Astellas appoints VP of Scientific and Medical Affairs
November 9, 2012Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss
Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …
Leadership changes at Teva
November 8, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva
Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …
Janssen and GSK in hep C tie-ups
November 8, 2012Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C
Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …
Goldacre is right – greater honesty is needed
November 7, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose
One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …
‘Patchy’ NHS Constitution needs improving
November 7, 2012Sales and Marketing DoH, Future Forum, NHS, commissioning
The NHS Future Forum has criticised the NHS Constitution for not being up to scratch and suggested ‘essential steps’ to …
Sanofi’s chief executive new president elect of EFPIA
November 7, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi
European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …
Takeda to buy Envoy Therapeutics
November 7, 2012Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda
Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …
Pfizer backs new biotech firm
November 6, 2012Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco
Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …
Pharma manufacturing news in brief
November 6, 2012Manufacturing and Production Cytovance, DSM, Insipiration, Neolpharma, Paranta, Patheon
A round up of recent pharma manufacturing news, including an Ipsen/Inspiration facility up for sale, new contracts for Patheon, Cytovance …
First Northern Ireland director for ABPI announced
November 6, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Colette Goldrick, Ireland
The ABPI has confirmed the appointment of Colette Goldrick as its new Northern Ireland director and as a member of …
MRC gives £7 million to new projects
November 6, 2012Sales and Marketing AstraZeneca, MRC, academics
The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …
New plant positions Lilly for changing insulin market
November 6, 2012Manufacturing and Production Boehringer, insulin, lilly
Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …
Further US approval for Xarelto
November 5, 2012Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto
US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …
Bayer to acquire Schiff Nutrition
November 4, 2012Sales and Marketing Bayer, mergers and acquisitions
Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …
Pfizer stumbles in third quarter
November 2, 2012Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3
Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
